About what are the leading stocks in the pharmaceutical sector?
Pharmaceutical sector leading stocks refers to the pharmaceutical industry in the market capitalization of the largest and strongest listed company stocks. These companies in the pharmaceutical manufacturing, biotechnology, the following editorial about the pharmaceutical sector leading stocks which are of great benefit to you, take a look together.
What are the leading stocks in the pharmaceutical sector
Pharmaceutical commercial leading stocks:
1, Shanghai Pharmaceuticals 601607: is China's pharmaceutical industry, "ten most influential enterprises" one of the market value of the circulation of the industry ranked first, 360. 17 billion yuan, the price-earnings ratio of 11. 81;
2, Jiuzhong, the market value of the industry, the price-earnings ratio of 11. 81;
2, the pharmaceutical industry is the most influential enterprises in the pharmaceutical industry. p>
2. Jiuzhou Tong 600998: is China's private pharmaceutical business ranked No. 1 enterprise, its circulation market capitalization in the industry ranked second, for 22.06 billion yuan, the price-earnings ratio of 18. 86;
3. Yifeng Pharmacy 603939: the main business for the retail business of pharmaceuticals, pharmaceuticals, wholesale business, as well as other business income, its circulation market capitalization in the industry ranked third, for 21.983 billion yuan, the price-earnings ratio of 11.81;
4. The market capitalization is 219.83 billion yuan, and the P/E ratio reaches 38.80.
What are the leading stocks of Chinese medicine sector
What are the leading stocks of Chinese medicine:1 Pientzehuang;2 Yunnan Baiyao;3 Jiuzhitang;4 Tongrentang;5 Baiyunshan;6 Jiangzhong Pharmaceuticals;7 Ma Yinglong. In addition, the Chinese medicine stocks are: Haiwang Biological, Fengyuan Pharmaceuticals, Dong'a Agaricus, Lizhu Group and so on. From the second half of last year, "the fifth batch of medicine collection" policy to carry out since the CSI pharmaceutical index has continued to retrace more than 20%, nearly a year dimension down -14%, while the CSI Chinese medicine index is "a standout", nearly a year up as much as nearly 40%, ranking first in the pharmaceutical sector. Ranked first in the pharmaceutical subsectors. 1, Tongrentang (600085): leading stocks of traditional Chinese medicine. October 22 news, Tongrentang as of 15:00, the stock rose 0.61%, at 33.11 yuan; 5 days within the share price fell 1.06%, the market value of 45.409 billion yuan.
The company has been listed for more than 10 years of growth and development, has formed to the core of the manufacturing of proprietary Chinese medicines, with the planting of Chinese herbal medicines, research and development of proprietary Chinese medicines, pharmaceutical logistics and distribution, pharmaceutical retailing of a more complete industrial chain.
2, Baiyunshan (600332): leading stocks of traditional Chinese medicine. October 22 news, Baiyunshan 5-day share price fell 0.5%, up 1.71% this year, the latest 29.8 yuan, the price-earnings ratio of 16.62.
Company is the domestic traditional Chinese medicine industry with the most varieties of the most complete, the largest number of Chinese old brand, the largest value of traditional Chinese medicine enterprises, traditional Chinese medicine varieties of more than 400 kinds, covering almost all of the traditional Chinese medicines. There are more than 400 kinds of traditional Chinese medicines, covering almost all traditional Chinese medicine classifications, 45 kinds of national Chinese medicine secondary protection varieties, of which more than 20 are exclusive production varieties, and there are more than 100 kinds of foreign brand-name pharmaceutical products exclusively represented by the company. Such as Wang Lao Ji, Chen Li Ji, Pan Gao Shou, Jing Xiu Tang, etc., all of which are long-established century-old stores. These include 20 exclusive products such as Quenching Thirst Pills and Hua Tuo Zaizao Pills. Wanglaoji Herbal Tea, Baoji Pills, Wu Ji Bai Feng Pills and other products are well-known in South China and Southeast Asia. After five enterprises, including Wanglaoji Pharmaceuticals and Jingxiutang Pharmaceuticals, were selected as the first batch of "old Chinese brands", three enterprises, including Zhongyi Pharmaceuticals, were selected as the second batch of "old Chinese brands".
What are the leading stocks in the biomedical sector
The biomedical sector is one of the hot industries in the current capital market, and there are a number of listed companies that have strong competitiveness and performance.
The stocks as the leading ones mainly include: United Amino Acids, Hengrui Medicine, WuXi Biotechnology, Myriad Medical and so on. These companies in the field of biopharmaceuticals, medical diagnostics, health services and other areas of high technology content and innovation, market prospects, investors can pay attention to these companies with leading potential, according to the actual situation of prudent investment.
What are the leading stocks of traditional Chinese medicine stocks
The leading stocks of traditional Chinese medicine are Guangxin Pharmaceuticals (300519), Xinzi Pharmaceuticals (002118), Shenlong Rongfa (300534), Yunnan Baiyao (00538), Tongrentang (600085), Pientzehuang (600436).
Expanded information:
1. Other Chinese medicine concept stocks include:
1. Taiantang:In the past 7 trading days, Taiantang dropped 20.26%, with the highest price of 6.48 yuan and the total market capitalization down 851 million yuan, or 20.26%.
2. Yisheng Pharmaceuticals:Reviewing the past 7 trading days, Yisheng Pharmaceuticals fell 6 days in a row. The full session fell 9.38%, the highest price of 8.58 yuan, the lowest price of 9.14 yuan,*** traded 40,196,600 lots.
3. Ealing Pharmaceuticals:Ealing Pharmaceuticals shares are down 15.08% in the last 7 days, up 2.26% in 2022, with a high price of $25.76 and a market capitalization of $34.784 billion.
What is the list of leading physician stocks?
Pharmaceutical and biological leading stocks are:Hengrui Medicine (600276), Fosun Pharmaceuticals (600196), Yunnan Baiyao (000538), Xinlite (002294), Kelaiyin (002821), Ai Er Ophthalmology (300015), Pientzehuang (600436).
Stock Name
Stock Code
Sector
Industry Class
Reason for Affiliation
Hengrui Medicine
600276
Shanghai
Chemistry Pharmaceuticals
It is the first and the leader in China's innovative drug development. It is a leading company in China's innovative drug field with a complete product mix and R&D channels. It is a leader in innovative drug development. Piratinib is independently developed by the company 1. An innovative drug is the company's heavy bomb product. Piratinib has a $1.4 billion market for breast cancer indications, and future indications will be expanded to include lung and stomach cancer.